EUVIMEDEUVIMED entdecken
Leserbrief

Ethics committees in India: A study to assess the implementation of registration requirements as per New Drug and Clinical Trial Rules and the scale of standardization

Murugananthan Krishnan, Haja S Sherief

The National Medical Journal of India · 27.12.2023 · 36 · 109-111

DOI: 10.25259/nmji_986_21 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The National Medical Journal of India, online erschienen am 27.12.2023. Verfasst von Murugananthan Krishnan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Global Drug Development, Novartis India Limited, INSPIRE BKC, Bandra Kurla Complex, Mumbai 400051, Maharashtra, India. Hauptthemen laut MEDLINE: Clinical Trials as Topic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicIndiaHumansEthics CommitteesDrug Approval

Autor:innen und Institutionen

  • Global Drug Development, Novartis India Limited, INSPIRE BKC, Bandra Kurla Complex, Mumbai 400051, Maharashtra, India.
  • Department of Pharmacology, Nanda College of Pharmacy, Erode, Koorapalayam 'Pirivu' Pitchandampalayam post, Erode 638052, Tamil Nadu, India.

Zitieren

APA

Krishnan, M., & Sherief, H. S. (2023). Ethics committees in India: A study to assess the implementation of registration requirements as per New Drug and Clinical Trial Rules and the scale of standardization. The National Medical Journal of India, 36, 109-111. https://doi.org/10.25259/nmji_986_21

Vancouver

Krishnan M, Sherief HS. Ethics committees in India: A study to assess the implementation of registration requirements as per New Drug and Clinical Trial Rules and the scale of standardization. The National Medical Journal of India. 2023;36:109-111. doi:10.25259/nmji_986_21

BibTeX
@article{Krishnan2023,
  author = {Krishnan, Murugananthan and Sherief, Haja S},
  title = {Ethics committees in India: A study to assess the implementation of registration requirements as per New Drug and Clinical Trial Rules and the scale of standardization},
  journal = {The National Medical Journal of India},
  year = {2023},
  volume = {36},
  pages = {109--111},
  doi = {10.25259/nmji_986_21}
}
Kostenlos starten →